Evaluation of Xpert^® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial

• Erick Wekesa Bunyasi ,

  Contributed equally to this work with: Erick Wekesa Bunyasi, Michele Tameris

  * E-mail: ebunyasi@gmail.com; bnyeri001@myuct.ac.za

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Michele Tameris ,

  Contributed equally to this work with: Erick Wekesa Bunyasi, Michele Tameris

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Hennie Geldenhuys,

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Bey-Marrie Schmidt,

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Angelique Kany Kany Luabeya,

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Humphrey Mulenga,

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Thomas J. Scriba,

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Willem A. Hanekom,

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯
• Hassan Mahomed,

  Affiliation Department of Health, Western Cape Province and Division of Community Health, Stellenbosch University, Stellenbosch, South Africa

  ⨯
• Helen McShane,

  Affiliation Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Mark Hatherill

  Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa

  ⨯